This clinical trial investigated the effects of a growth hormone-releasing hormone (GHRH) antagonist on plasma growth hormone (GH) levels in healthy individuals. The results showed that the GHRH antagonist significantly reduced GH secretion, demonstrating the pivotal role of endogenous GHRH in regulating GH release. This finding suggests that GHRH antagonists
